Award Date: 2018
Project Lead(s): Brad Buchsbaum
Project Title: Assessment of a Novel MRI Image Analysis Software Platform for Detecting Alzheimer’s Disease
Darmiyan is partnering with Baycrest, Hamilton Health Sciences, and the University Health Network to test their new MRI-based solution, which predicts whether pre-symptomatic and symptomatic individuals with cognitive impairment will develop Alzheimer’s disease. Darmiyan’s MRI-based predictions will be compared against gold-standard clinical assessments using retrospective and/or prospective study approaches.